Bridging the gap: From discovery to clinical trials in spinal cord injury

被引:17
作者
Hulsebosch, CE
Hains, BC
Waldrep, K
Young, W
机构
[1] Inst Marine Biomed, Dept Anat & Neurosci, Galveston, TX 77555 USA
[2] Kent Waldrep Natl Paralysis Fdn, Dallas, TX USA
[3] Rutgers State Univ, Nelson Biol Labs, Piscataway, NJ USA
关键词
clinical trials; human; spinal cord injury;
D O I
10.1089/neu.2000.17.1117
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Recently, the Kent Waldrep National Paralysis Foundation initiated a think tank intended to bridge several gaps and achieve several goals in regard to spinal cord injury (SCI) research and funding. Affiliated with the need to bridge a pathophysiological gap in spinal parenchyma and/or reorganize remaining circuitry after injury is a need to bridge resource gaps for timely funding for translational research, gaps in knowledge between researchers, and between researchers/clinicians and SCI patients. The epistemology of cure was examined and redefined to include transitional recoveries and advances. Modes and mechanisms of funding have been evaluated and where deficits were perceived, suggestions have been made to expedite and increase the number and breadth of funding opportunities. Innovative infrastructure changes are submitted. We discuss the progression of clinical trials as well as offer suggestions to facilitate benchtop-to-bedsite translation of valuable research to the customer. Highlights of recently completed, in progress, and future trials are detailed. Finally, we submit five essential processes required to promote advances to the SCI patient population: discovery, development, clinical trials, evaluation, and rehabilitation. These ideas are intended to facilitate entry of serious dialogue and to ultimately improve the lives of patients living with SCI.
引用
收藏
页码:1117 / 1128
页数:12
相关论文
共 70 条
  • [1] ABEL NA, 1994, ARCH PHYS MED REHAB, V75, P54
  • [2] Management of chronic pain
    Ashburn, MA
    Staats, PS
    [J]. LANCET, 1999, 353 (9167) : 1865 - 1869
  • [3] Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: A pilot study
    Attal, N
    Brasseur, L
    Parker, F
    Chauvin, M
    Bouhassira, D
    [J]. EUROPEAN NEUROLOGY, 1998, 40 (04) : 191 - 200
  • [4] Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-up
    Azouvi, P
    Mane, M
    Thiebaut, JB
    Denys, P
    RemyNeris, O
    Bussel, B
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (01): : 35 - 39
  • [5] POSTTRAUMATIC SPINAL-CORD CYSTS EVALUATED BY MAGNETIC-RESONANCE-IMAGING
    BACKE, HA
    BETZ, RR
    MESGARZADEH, M
    BECK, T
    CLANCY, M
    [J]. PARAPLEGIA, 1991, 29 (09): : 607 - 612
  • [6] BAJD T, 1984, J BIOMED ENG, V6, P9, DOI 10.1016/0141-5425(84)90003-7
  • [7] BARBEAU H, 1991, RES NEUROL, V5, P461
  • [8] Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive suppression of temporal muscle activity in patients with chronic tension-type headache
    Bendtsen, L
    Jensen, R
    Olesen, J
    [J]. ELECTROMYOGRAPHY AND MOTOR CONTROL-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1996, 101 (05): : 418 - 422
  • [9] Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
    Bethea, JR
    Nagashima, H
    Acosta, MC
    Briceno, C
    Gomez, F
    Marcillo, AE
    Loor, K
    Green, J
    Dietrich, WD
    [J]. JOURNAL OF NEUROTRAUMA, 1999, 16 (10) : 851 - 863
  • [10] EFFECTS OF TIMING OF METHYLPREDNISOLONE OR NALOXONE ADMINISTRATION ON RECOVERY OF SEGMENTAL AND LONG-TRACT NEUROLOGICAL FUNCTION IN NASCIS-2
    BRACKEN, MB
    HOLFORD, TR
    [J]. JOURNAL OF NEUROSURGERY, 1993, 79 (04) : 500 - 507